Φορτώνει......
Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada
BACKGROUND: Every year, over 1 million people develop isoniazid (INH) resistant tuberculosis (TB). Yet, the optimal treatment regimen remains unclear. Given increasing prevalence, the clinical efficacy of regimens used by physicians is of interest. This study aims to examine treatment outcomes of IN...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | BMC Infect Dis |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5583994/ https://ncbi.nlm.nih.gov/pubmed/28870175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2706-0 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|